A NOVEL ENDOLUMINAL FUNDOPLICATION FOR PROTON PUMP INHIBITOR-REFRACTORY GASTROESOPHAGEAL REFLUX DESEASE (GERD) -ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GERD (ESD-G)

被引：1
|
作者：
Ota, Kazuhiro [1 ]
Takeuchi, Toshihisa [1 ]
Kojima, Yuichi [1 ]
Harada, Satoshi [1 ]
Sugawara, Noriaki [1 ]
Higuchi, Kazuhide [1 ]
机构：
[1] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka, Japan
来源：
GASTROINTESTINAL ENDOSCOPY | 2019年 / 89卷 / 06期
关键词：
D O I：
10.1016/j.gie.2019.03.1158
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu2014
引用
收藏
页码：AB657 / AB658
页数：2
相关论文
共 50 条
  • [21] Evaluation of Proton-Pump-Inhibitor (PPI) -Resistant Gastroesophageal Reflux Disease (GERD) By Esophageal Motility Tests
    Kawaguchi, Shinpei
    Takeuchi, Toshihisa
    Takahashi, Yoshiaki
    Harada, Satoshi
    Ota, Kazuhiro
    Kojima, Yuichi
    Higuchi, Kazuhide
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB586 - AB586
  • [22] Cost analysis of a new proposal for reimbursement of proton pump inhibitor treatment of gastroesophageal reflux disease (GERD) in Belgium
    Van Wilder, PB
    Arickx, F
    Vannecke, C
    Hiele, M
    Verpooten, GA
    VALUE IN HEALTH, 2003, 6 (06) : 685 - 686
  • [23] Patient and Physician Perceptions on Dosing Directions for Proton Pump Inhibitor (PPI) in the Treatment of Gastroesophageal Reflux Disease (GERD)
    Solem, Caitlyn
    Mody, Reema
    Stephens, Jennifer
    Macahilig, Cynthia
    Carpiuc, Kim Tran
    Gao, Xin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S411 - S411
  • [24] Predictors for treatment failure of on-demand proton pump inhibitor (PPI) therapy in gastroesophageal reflux disease (GERD)
    Wu, Justin
    Cheung, Carnan
    Wong, Vincent
    Sung, Joseph
    GASTROENTEROLOGY, 2006, 130 (04) : A172 - A172
  • [25] The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease
    Ogawa, Maiko
    Arihiro, Seiji
    Matsuhashi, Nobuyuki
    Joh, Takashi
    Higuchi, Kazuhide
    Iwakiri, Katsuhiko
    Kamiya, Takeshi
    Manabe, Noriaki
    Isshi, Kimio
    Nakada, Tatsuya
    Hokari, Atsushi
    Saruta, Masayuki
    Oshio, Atsushi
    Haruma, Ken
    Nakada, Koji
    ESOPHAGUS, 2021, 18 (02) : 398 - 406
  • [26] The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease
    Maiko Ogawa
    Seiji Arihiro
    Nobuyuki Matsuhashi
    Takashi Joh
    Kazuhide Higuchi
    Katsuhiko Iwakiri
    Takeshi Kamiya
    Noriaki Manabe
    Kimio Isshi
    Tatsuya Nakada
    Atsushi Hokari
    Masayuki Saruta
    Atsushi Oshio
    Ken Haruma
    Koji Nakada
    Esophagus, 2021, 18 : 398 - 406
  • [27] ARBACLOFEN PLACARBIL IMPROVES SLEEP QUALITY IN PATIENTS WITH PROTON PUMP INHIBITOR (PPI)-RESPONSIVE GASTROESOPHAGEAL REFLUX DISEASE (GERD)
    Fass, R.
    Vakil, N.
    Huff, F.
    Jones, D.
    Bian, A.
    Stamler, D.
    SLEEP, 2010, 33 : A291 - A292
  • [28] The Value of Upper Endoscopy in Patients with Gastroesophageal Reflux Disease (GERD) Who Failed Proton Pump Inhibitor (PPI) Therapy
    Van Handal, Dan
    Hussain, Feroze
    Bhatt, Rajan
    Dickman, Ram
    Hernandez, Diley
    Fass, Ronnie
    GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB139 - AB139
  • [29] PROTON PUMP INHIBITOR (PPI) TEST FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD): OPTIMAL CUT-OFF VALUE AND DURATION
    Pace, F.
    de Leone, A.
    Casini, V.
    Tonini, M.
    Dominici, P.
    Grossi, E.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S177 - S177
  • [30] Correction to: The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease
    Maiko Ogawa
    Seiji Arihiro
    Nobuyuki Matsuhashi
    Takashi Joh
    Kazuhide Higuchi
    Katsuhiko Iwakiri
    Takeshi Kamiya
    Noriaki Manabe
    Kimio Isshi
    Tatsuya Nakada
    Atsushi Hokari
    Masayuki Saruta
    Atsushi Oshio
    Ken Haruma
    Koji Nakada
    Esophagus, 2021, 18 : 711 - 712
12345